Dr. Bishoy M. Faltas

Good time to read our Tweetorial/ X-planation of our nature.com/articles/s4158… paper now featured on the cover of @Nature!

Also, if you are looking for a postdoc position and attending AUA/SBUR, we are hiring! Application instructions below, with the possibility of meeting there if there is a strong fit. x.com/FaltasLab/stat…

Can distinct forms of transient genotoxic stress leave a lasting cellular memory that reprograms cells? If you are curious about this question, come to my talk: “The Hidden Memory of DNA Damage: DASP in Bladder Cancer Evolution and Resistance” at the Society for Basic Urologic Research @UrologySBUR @AmerUrological #AUA2026. I will present a new story that my lab has been working on for a while! Looking forward to seeing friends and colleagues and discussing #BladderCancer #DASP #CancerEvolution #AUA2026 #FaltasLab @WCMGUcancer @WeillCornell. This session features a fantastic lineup of speakers spanning bladder, kidney, and prostate cancer biology.

@DrShariat Congratulations!

Proud to launch StrikeBC — a new bladder cancer study bringing together 10 centers, great people, and one goal: to improve the lives of patients with bladder cancer from every angle — through collaboration, science, and care. #StrikeBC #BladderCancer on.orf.at/video/14322396…

@LauraBukavinaMD @CCLRI @CleClinicUro @gabrielamdd @AmandaNizamMD @ChrisWeeMD @CanDAydogdu @hjwang26 @cjweight @SeanTMcSweeney @AIwithMSD @IlahaIsali @LauraElizaDavis Congratulations!

🚨 New pub alert @CCLRI @CleClinicUro by our @gabrielamdd ❗️Young onset #bladdercancer is on the rise and it's hitting young women hardest 🔬 299,272 patients (TriNetX) + 4,571 (UK Biobank) 📈 Incidence climbing fastest in <50 cohort 👩 Women = 38.9% of <50 cases vs 18.9% of ≥50.. trends NONE of us want to see but reflected in practice sciencedirect.com/science/articl…

@ZiadBakouny @MSK_DeptOfMed @EdReznik @motzermd @arihakimi Congratulations!

Thrilled to receive the Gerstner Physician Scholars’ grant! The grant will support our work for the next 3 years on mitochondrial DNA mutations in cancer. Very thankful for the mentorship from Craig Thompson, @EdReznik, @motzermd, @arihakimi and many others! @MSK_DeptOfMed

Daraxonrasib in Previously Treated Advanced RAS-Mutated #PancreaticCancer (Phase 1-2 study) nejm.org/doi/pdf/10.105… @RevMedicines @salmanpunekar

@DRMP2025 @psscra Congratulations!

I’m incredibly grateful to @psscra for the Pershing Square Sohn Cancer Prize, recognizing our work and enabling an important part of our broader vision to develop personalized cancer prevention strategies 🙏

@DinaPowellMcC @Meta @MilkenInstitute This is spot on! AI is rewiring the global economy “like 10 Manhattan Projects going off all at once.” With @Meta scale investments, the collaborative opportunities for cancer research and precision medicine are enormous! marketwatch.com/story/like-10-…

AI is a group sport — built on partnerships. It will take significant capital, energy, and talent to achieve. @Meta believes that superintelligence can empower people to reach their potential.

Please join us on May 18 for our NMIBC workshop. Honored to be joined by a wonderful lineup of panelists including @UroDocAsh @djmcconkey @garysteinbergmd @h_alahmadie @MaxKates @pjhensley11 @spsutkaMD @pcvblack @FaltasLab @MattGalsky @drdonnahansel @ERPlimackMD @SimaPorten

@Poulikos Congratulations!

Grateful to the MRA for the confidence in our work

With hard work, focus, and the determination to finish what we start, I am sure there are many more achievements ahead of you. Keep up the good work Mohamed Osman ! #ProudPI

@airdlab @LyssiotisLab Amazing lab, highly recommend!

Our lab is expanding and hiring both a postdoc and staff scientist! We study how metabolism and cell cycle states drive tumor progression, therapy response, and immune interactions. Philly is a great place to live and do research! See more at: airdlab.com.

@StanfordUrology @liaojoe1 @StanfordMed @AmerUrological Congratulations!

We are pleased to announce the appointment of Joseph Liao, MD, as the next Chair of the Department of Urology, effective August 1. Read the full announcement from Dean Lloyd Minor: urology.stanford.edu/news/04-24-202… @liaojoe1 @StanfordMed @AmerUrological

@CharlesSwanton @CR_UK @CRUKLungCentre @UCLHresearch Congratulations!

Online here: nature.com/articles/s4158… Open access here: rdcu.be/ff6YJ Key supporters of this work are @CR_UK , @CRUKLungCentre , @UCLHresearch alongside many others

Excited to share our ‘Evolutionary characterization of #LungCancer metastasis’ in #TRACERx & #PEACE, published today in @Nature: a decade spanning effort led by the Jamal-Hanjani lab, @SwantonLab, @NickyMcGranahan & @ZaccaSimo at @uclcancer & @TheCrick. Link below

@UTMDAnderson @IamLinghua Congratulations!

A generous gift from Peggy and Carl Sewell led to the establishment of the Center for Cellular Language Intelligence. Dr. Linghua Wang will lead the research to understand cellular behaviors at unprecedented resolution: spr.ly/6011BBMLHd @iamlinghua #EndCancer

@emanuele_crupi @mjmoussa_ @ASCO @ConquerCancerFd @UTMDAnderson @DocMattCampbell @OAlhalabiMD @UroDocAsh @PavlosMsaouel @DrZachariahT @oncodaily @glovedoc @BladderCancerUS @CYJiangMD Congratulations!

Honored to receive this prestigious recognition from @ASCO & @ConquerCancerFd! Grateful to the Stadler family for their generosity. Deeply thankful to my @UTMDAnderson family & mentors, Drs. JJ Gao and Siefker-Radtke, for their unwavering support. #EndCancer #ASCO26

Relay announces data for Zovegalisib (PI3Ki) plus Atirmociclib (CDK4i) Triplet Combination in late line MBC: 44% ORR in heavily pre-treated, CDK4/6-experienced patients (median third-line). Plan to start a first-line phase 3 trial in 2026. globenewswire.com/news-release/2…

@efapostolou29 @AACR @pfizer Congratulations Effie!

Incredibly honored to be awarded a highly competitive AACR Trailblazer Cancer grant and so grateful to @AACR and @pfizer for the generous support! In such challenging times, researchers need more initiatives like this for catalyzing innovation and sustaining progress.

WCMEnglanderIPM

It was great to see friends and colleagues at the #AACR26 annual grantee recognition event to receive the first @AACR Innovative Bladder Cancer Research Award! Congratulations to #Faltaslab postdoc @MHosmanMD who received the AACR-EMD Serono fellowship and to my friend and colleague @efapostolou29 for her trailblazer award! Very well deserved @WCM_MeyerCancer @WCMDeptofMed @WeillCornell

@MHosmanMD also got to show @AACR_CEO Dr. Foti the tremendous impact of earlier @AACR support on his career. Thank you @AACR for supporting the careers of cancer researchers at all stages. Research saves lives!